Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

NCT03165526 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03165526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
November 29, 2021
Enrollment
131 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

post-infarction ventricular septal defect